MXPA02007473A - Moleculas activadoras de celulas presentadoras de antigenos (apc) que se unen a cd40. - Google Patents
Moleculas activadoras de celulas presentadoras de antigenos (apc) que se unen a cd40.Info
- Publication number
- MXPA02007473A MXPA02007473A MXPA02007473A MXPA02007473A MXPA02007473A MX PA02007473 A MXPA02007473 A MX PA02007473A MX PA02007473 A MXPA02007473 A MX PA02007473A MX PA02007473 A MXPA02007473 A MX PA02007473A MX PA02007473 A MXPA02007473 A MX PA02007473A
- Authority
- MX
- Mexico
- Prior art keywords
- activating molecules
- binding
- apc activating
- binding apc
- molecules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17893400P | 2000-02-01 | 2000-02-01 | |
PCT/US2001/003378 WO2001056603A1 (en) | 2000-02-01 | 2001-02-01 | Cd40-binding apc-activating molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02007473A true MXPA02007473A (es) | 2003-09-22 |
Family
ID=22654507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02007473A MXPA02007473A (es) | 2000-02-01 | 2001-02-01 | Moleculas activadoras de celulas presentadoras de antigenos (apc) que se unen a cd40. |
Country Status (9)
Country | Link |
---|---|
US (3) | US7172759B2 (es) |
EP (2) | EP1975182A1 (es) |
JP (1) | JP2003524644A (es) |
CN (2) | CN100490895C (es) |
AU (2) | AU3662101A (es) |
BR (1) | BR0108001A (es) |
CA (1) | CA2398998C (es) |
MX (1) | MXPA02007473A (es) |
WO (1) | WO2001056603A1 (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407218B1 (en) * | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
CA2223225A1 (en) * | 1997-11-28 | 1999-05-28 | Canadian Red Cross Society | Method for inhibiting in vivo immune response |
US20110041190A1 (en) * | 2002-10-31 | 2011-02-17 | Tykocinski Mark L | Novel chimeric proteins |
EP1975182A1 (en) * | 2000-02-01 | 2008-10-01 | PanGenetics B.V. | CD40-binding APC-activating molecules |
US7063845B2 (en) | 2000-04-28 | 2006-06-20 | Gemini Science, Inc. | Human anti-CD40 antibodies |
CA2658221C (en) | 2001-04-27 | 2012-11-27 | Kyowa Hakko Kirin Co., Ltd. | Anti-cd40 monoclonal antibody |
US20030091593A1 (en) * | 2001-09-14 | 2003-05-15 | Cytos Biotechnology Ag | In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles |
AU2002339224B2 (en) | 2001-09-14 | 2008-10-09 | Kuros Us Llc | Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
AR039067A1 (es) * | 2001-11-09 | 2005-02-09 | Pfizer Prod Inc | Anticuerpos para cd40 |
EP1605973B1 (en) | 2003-03-26 | 2012-09-26 | Cytos Biotechnology AG | Packaging of immunostimulatory oligonucleotides into virus-like particles: methods of preparation and uses |
US7537767B2 (en) | 2003-03-26 | 2009-05-26 | Cytis Biotechnology Ag | Melan-A- carrier conjugates |
JP2008504216A (ja) * | 2003-12-02 | 2008-02-14 | サイトイミューン サイエンシズ インコーポレイテッド | モノクローナル抗体の生成のための方法および組成物 |
US20050136055A1 (en) | 2003-12-22 | 2005-06-23 | Pfizer Inc | CD40 antibody formulation and methods |
US20070184068A1 (en) | 2005-12-14 | 2007-08-09 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
MX2008013993A (es) | 2006-05-03 | 2009-05-11 | Univ Colorado | Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular. |
PL2032592T3 (pl) | 2006-06-12 | 2013-11-29 | Kuros Biosciences Ag | Sposoby pakowania oligonukleotydów do cząstek wirusopodobnych z bakteriofagów RNA |
US20090074711A1 (en) * | 2006-09-07 | 2009-03-19 | University Of Southhampton | Human therapies using chimeric agonistic anti-human cd40 antibody |
CA2706700A1 (en) * | 2007-11-08 | 2009-05-14 | Cytimmune Sciences, Inc. | Compositions and methods for generating antibodies |
WO2012042480A1 (en) | 2010-09-28 | 2012-04-05 | Kahr Medical Ltd. | Compositions and methods for treatment of hematological malignancies |
CA3122934A1 (en) | 2011-03-11 | 2012-09-20 | Beth Israel Deaconess Medical Center, Inc. | Fusion protein comprising a fragment of cd40 and method of producing same |
MX339239B (es) | 2011-04-29 | 2016-05-18 | Apexigen Inc | Anticuerpos anti-cd40 y metodos de uso. |
CN104918957B (zh) | 2012-10-30 | 2018-11-16 | 埃派斯进有限公司 | 抗-cd40抗体及其使用方法 |
CN103793594A (zh) * | 2013-12-30 | 2014-05-14 | 上海交通大学医学院附属瑞金医院 | 一种构建肠道-胰岛调控轴相关功能评估模型的方法与应用 |
WO2016033690A1 (en) * | 2014-09-04 | 2016-03-10 | Stemcell Technologies Inc. | Soluble antibody complexes for t cell or nk cell activation and expansion |
KR102656470B1 (ko) | 2014-12-10 | 2024-04-09 | 리전츠 오브 더 유니버스티 오브 미네소타 | 질환을 치료하기 위한 유전적으로 변형된 세포, 조직 및 장기 |
US20170316176A1 (en) * | 2014-12-25 | 2017-11-02 | Hitachi, Ltd. | Device for analyzing insulin secretion ability, system for analyzing insulin secretion ability provided with same, and method for analyzing insulin secretion ability |
MA41459A (fr) | 2015-02-03 | 2017-12-12 | Als Therapy Development Inst | Anticorps anti-cd40l et méthodes pour traiter des maladies ou des troubles liés aux cd40l |
WO2016130667A1 (en) | 2015-02-10 | 2016-08-18 | Ohio State Innovation Foundation | Chlamydia-activated b cell platforms and methods thereof |
WO2016166568A1 (en) | 2015-04-16 | 2016-10-20 | Juno Therapeutics Gmbh | Methods, kits and apparatus for expanding a population of cells |
JP2018521983A (ja) | 2015-07-16 | 2018-08-09 | バイオカイン セラピューティックス リミテッド | がんを治療するための組成物および方法 |
SI3307322T1 (sl) | 2015-09-04 | 2021-08-31 | Primatope Therapeutics Inc. | Humanizirana protitelesa proti CD40 in njihove uporabe |
EP3355921A4 (en) | 2015-09-30 | 2019-05-22 | Janssen Biotech, Inc. | ANTAGONIST ANTIBODIES SPECIFICALLY BINDING TO HUMAN CD40 AND METHODS OF USE |
MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
MA45488A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés, kits et appareil de culture de cellules |
BR112018008891A8 (pt) | 2015-11-03 | 2019-02-26 | Janssen Biotech Inc | anticorpos que se ligam especificamente a pd-1 e tim-3 e seus usos |
US10835601B2 (en) | 2015-11-10 | 2020-11-17 | Ohio State Innovation Foundation | Methods and compositions related to accelerated humoral affinity |
EP3426271A4 (en) | 2016-03-10 | 2019-10-16 | Cold Genesys, Inc. | METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY POLYTHERAPY |
KR102426765B1 (ko) * | 2016-04-22 | 2022-07-29 | 엘리게이터 바이오사이언스 에이비 | Cd137에 대한 신규한 이중특이성 폴리펩타이드 |
AU2017271601A1 (en) | 2016-05-27 | 2018-12-13 | Abbvie Biotherapeutics Inc. | Bispecific binding proteins binding an immunomodulatory protein and a tumor antigen |
MX2018014630A (es) | 2016-05-27 | 2019-06-10 | Abbvie Biotherapeutics Inc | Anticuerpos anti-cd40 y sus usos. |
US11091557B2 (en) | 2016-07-14 | 2021-08-17 | Genmab A/S | Methods of producing multispecific antibodies against CD40 and CD137 |
AU2017308734A1 (en) | 2016-08-12 | 2019-02-14 | Janssen Biotech, Inc. | Fc engineered anti-TNFR superfamily member antibodies having enhanced agonistic activity and methods of using them |
SG11201900746RA (en) | 2016-08-12 | 2019-02-27 | Janssen Biotech Inc | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions |
JP7305538B2 (ja) | 2016-09-23 | 2023-07-10 | メルス ナムローゼ フェンノートシャップ | 細胞によって発現される生物活性を調節する結合分子 |
CA3055433A1 (en) * | 2017-03-29 | 2018-10-04 | Glycotope Gmbh | Humanized anti-cd40 antibodies |
KR102606210B1 (ko) | 2017-04-27 | 2023-11-24 | 주노 테라퓨틱스 게엠베하 | 올리고머 입자 시약 및 이의 사용 방법 |
WO2018217918A2 (en) | 2017-05-24 | 2018-11-29 | Als Therapy Development Institute | Therapeutic anti-cd40 ligand antibodies |
WO2019016402A1 (en) | 2017-07-20 | 2019-01-24 | Aptevo Research And Development Llc | BINDING PROTEINS BINDING AT 5T4 AND 4-1BB, COMPOSITIONS AND METHODS RELATED THERETO |
JP2022512872A (ja) | 2018-10-31 | 2022-02-07 | ジュノ セラピューティクス ゲーエムベーハー | 細胞の選択および刺激のための方法ならびにそのための装置 |
CA3117720A1 (en) | 2018-11-06 | 2020-05-14 | Juno Therapeutics, Inc. | Process for producing genetically engineered t cells |
CN109912717B (zh) * | 2019-03-04 | 2020-05-26 | 北京天广实生物技术股份有限公司 | 结合cd40的抗体及其用途 |
AU2020377043A1 (en) | 2019-10-30 | 2022-06-02 | Juno Therapeutics Gmbh | Cell selection and/or stimulation devices and methods of use |
CA3164129A1 (en) | 2019-12-20 | 2021-06-24 | Amgen Inc. | Mesothelin-targeted cd40 agonistic multispecific antibody constructs for the treatment of solid tumors |
CN111235208B (zh) * | 2020-02-28 | 2022-10-28 | 江苏大学 | 一种离子液体对糖代谢影响的评估方法 |
WO2021231661A2 (en) | 2020-05-13 | 2021-11-18 | Juno Therapeutics, Inc. | Process for producing donor-batched cells expressing a recombinant receptor |
WO2022036495A1 (en) | 2020-08-17 | 2022-02-24 | Utc Therapeutics Inc. | Lymphocytes-antigen presenting cells co-stimulators and uses thereof |
CN117916256A (zh) | 2021-05-06 | 2024-04-19 | 朱诺治疗学有限公司 | 用于刺激和转导t细胞的方法 |
WO2023213969A1 (en) | 2022-05-05 | 2023-11-09 | Juno Therapeutics Gmbh | Viral-binding protein and related reagents, articles, and methods of use |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US6106835A (en) * | 1991-04-19 | 2000-08-22 | Tanox, Inc. | Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators |
US5637481A (en) * | 1993-02-01 | 1997-06-10 | Bristol-Myers Squibb Company | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
DE69334255D1 (de) | 1992-02-06 | 2009-02-12 | Novartis Vaccines & Diagnostic | Marker für Krebs und biosynthetisches Bindeprotein dafür |
ES2211884T3 (es) | 1993-10-01 | 2004-07-16 | Immunex Corporation | Anticuerpos contra el cd40. |
ATE267607T1 (de) | 1993-12-23 | 2004-06-15 | Immunex Corp | Verwendung von löslichen oligomerischen cd40 liganden oder monoklonalen antikörpern zur herstellung eines arzneimitells zur vorbeugung oder behandlung von neoplastischen krankheiten |
US5463564A (en) | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
US5504004A (en) | 1994-12-20 | 1996-04-02 | Michigan Biotechnology Institute | Process for making succinic acid, microorganisms for use in the process and methods of obtaining the microorganisms |
WO1998001473A1 (en) | 1996-07-05 | 1998-01-15 | Novo Nordisk A/S | Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides |
DE29611914U1 (de) | 1996-07-09 | 1997-11-06 | Bosch Gmbh Robert | Zündspule für eine Brennkraftmaschine |
NZ333607A (en) * | 1996-07-10 | 2000-08-25 | Immunex Corp | Method of stimulating the immune system by transfecting dendritic cells |
WO1999061057A2 (en) * | 1998-05-23 | 1999-12-02 | Tanox, Inc. | Molecules targeting cd40 and tumor cells |
EP1082141B1 (en) * | 1998-05-23 | 2005-09-14 | Leiden university medical center | Cd40 binding antibodies and ctl peptides for treating tumors |
US6946129B1 (en) * | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
EP1975182A1 (en) * | 2000-02-01 | 2008-10-01 | PanGenetics B.V. | CD40-binding APC-activating molecules |
AU2001259106A1 (en) | 2000-04-19 | 2002-02-18 | Tanox, Inc. | CD40 antagonists for use in treating psoriasis and other inflammatory skin conditions |
JP4483043B2 (ja) * | 2000-07-19 | 2010-06-16 | ヤマハ株式会社 | 楽曲データ提供装置、方法、及び記録媒体 |
-
2001
- 2001-02-01 EP EP08157131A patent/EP1975182A1/en not_active Withdrawn
- 2001-02-01 JP JP2001556502A patent/JP2003524644A/ja active Pending
- 2001-02-01 CA CA2398998A patent/CA2398998C/en not_active Expired - Lifetime
- 2001-02-01 WO PCT/US2001/003378 patent/WO2001056603A1/en active Application Filing
- 2001-02-01 US US09/773,866 patent/US7172759B2/en not_active Expired - Lifetime
- 2001-02-01 CN CNB018072453A patent/CN100490895C/zh not_active Expired - Fee Related
- 2001-02-01 EP EP01908789A patent/EP1253942A4/en not_active Ceased
- 2001-02-01 BR BR0108001-6A patent/BR0108001A/pt not_active IP Right Cessation
- 2001-02-01 AU AU3662101A patent/AU3662101A/xx active Pending
- 2001-02-01 MX MXPA02007473A patent/MXPA02007473A/es unknown
- 2001-02-01 AU AU2001236621A patent/AU2001236621B2/en not_active Ceased
- 2001-04-26 CN CNA018117716A patent/CN1942767A/zh active Pending
-
2006
- 2006-12-20 US US11/613,409 patent/US7547438B2/en not_active Expired - Fee Related
-
2009
- 2009-04-08 US US12/420,481 patent/US7820807B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7547438B2 (en) | 2009-06-16 |
BR0108001A (pt) | 2004-01-06 |
EP1253942A4 (en) | 2004-06-16 |
US20010026932A1 (en) | 2001-10-04 |
US7172759B2 (en) | 2007-02-06 |
US7820807B2 (en) | 2010-10-26 |
JP2003524644A (ja) | 2003-08-19 |
AU3662101A (en) | 2001-08-14 |
CA2398998C (en) | 2014-04-22 |
WO2001056603A1 (en) | 2001-08-09 |
CN100490895C (zh) | 2009-05-27 |
US20070098720A1 (en) | 2007-05-03 |
US20090311268A1 (en) | 2009-12-17 |
EP1253942A1 (en) | 2002-11-06 |
EP1975182A1 (en) | 2008-10-01 |
CA2398998A1 (en) | 2001-08-09 |
CN1443077A (zh) | 2003-09-17 |
AU2001236621B2 (en) | 2006-06-15 |
CN1942767A (zh) | 2007-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02007473A (es) | Moleculas activadoras de celulas presentadoras de antigenos (apc) que se unen a cd40. | |
ZA200205479B (en) | Novel biarylcarboxamides. | |
AU2001291200A1 (en) | Micro-laser | |
MXPA03002410A (es) | 4-amino-quinazolinas. | |
AU2002239660A1 (en) | Watermaking holograms | |
MXPA03005445A (es) | Barra colectora 12c para aislar los circuitos integrados seleccionados para una comunicacion rapida de barra colectora 12c. | |
MXPA03007197A (es) | Moleculas de enlace terapeuticas. | |
EG23262A (en) | Delta -pyrrolines. | |
AUPQ632300A0 (en) | Bactericidal solution | |
HK1056872A1 (en) | Indoloquinazolinones. | |
MXPA03001877A (es) | 2-guanidin-4-arilquinazolinas. | |
MXPA03001591A (es) | Derivados y analogos de 10-aril-11-h-benzo(b) fluorena para uso medicinal. | |
ZA200205389B (en) | Booklet. | |
MXPA03002668A (es) | Guanidinas de sulfonilo. | |
MXPA03001991A (es) | Novedosas arilalcano-sulfonamidas. | |
MXPA03005714A (es) | Sulfamidotienopirimidinas. | |
MXPA03002411A (es) | 4-amino-quinazolinas. | |
AU6594401A (en) | 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines | |
AU2001259434A1 (en) | Calcitonin-related molecules | |
MXPA03005494A (es) | Benzoilpiridazinas. | |
AU2002210379A1 (en) | Subtilase variants | |
HK1061560A1 (en) | Triazolo-epothilones. | |
MXPA03004202A (es) | Producto celulosico entrelazado. | |
GB0022670D0 (en) | Molecules | |
GB0002625D0 (en) | Dendroaspin molecules |